rs2275276

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_015506.3(MMACHC):​c.321G>A​(p.Val107=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.445 in 1,613,554 control chromosomes in the GnomAD database, including 161,108 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. VHPN107VH?) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.44 ( 14708 hom., cov: 31)
Exomes 𝑓: 0.45 ( 146400 hom. )

Consequence

MMACHC
NM_015506.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.875
Variant links:
Genes affected
MMACHC (HGNC:24525): (metabolism of cobalamin associated C) The exact function of the protein encoded by this gene is not known, however, its C-terminal region shows similarity to TonB, a bacterial protein involved in energy transduction for cobalamin (vitamin B12) uptake. Hence, it is postulated that this protein may have a role in the binding and intracellular trafficking of cobalamin. Mutations in this gene are associated with methylmalonic aciduria and homocystinuria type cblC. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 1-45508256-G-A is Benign according to our data. Variant chr1-45508256-G-A is described in ClinVar as [Benign]. Clinvar id is 95702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-45508256-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.875 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.557 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MMACHCNM_015506.3 linkuse as main transcriptc.321G>A p.Val107= synonymous_variant 3/4 ENST00000401061.9
MMACHCNM_001330540.2 linkuse as main transcriptc.150G>A p.Val50= synonymous_variant 3/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MMACHCENST00000401061.9 linkuse as main transcriptc.321G>A p.Val107= synonymous_variant 3/42 NM_015506.3 P1
MMACHCENST00000616135.1 linkuse as main transcriptc.150G>A p.Val50= synonymous_variant 3/52

Frequencies

GnomAD3 genomes
AF:
0.437
AC:
66417
AN:
151816
Hom.:
14714
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.376
Gnomad AMI
AF:
0.488
Gnomad AMR
AF:
0.481
Gnomad ASJ
AF:
0.477
Gnomad EAS
AF:
0.575
Gnomad SAS
AF:
0.501
Gnomad FIN
AF:
0.481
Gnomad MID
AF:
0.418
Gnomad NFE
AF:
0.441
Gnomad OTH
AF:
0.432
GnomAD3 exomes
AF:
0.472
AC:
117763
AN:
249396
Hom.:
28151
AF XY:
0.471
AC XY:
63786
AN XY:
135322
show subpopulations
Gnomad AFR exome
AF:
0.370
Gnomad AMR exome
AF:
0.554
Gnomad ASJ exome
AF:
0.474
Gnomad EAS exome
AF:
0.579
Gnomad SAS exome
AF:
0.486
Gnomad FIN exome
AF:
0.482
Gnomad NFE exome
AF:
0.439
Gnomad OTH exome
AF:
0.461
GnomAD4 exome
AF:
0.446
AC:
652152
AN:
1461620
Hom.:
146400
Cov.:
57
AF XY:
0.448
AC XY:
325412
AN XY:
727140
show subpopulations
Gnomad4 AFR exome
AF:
0.366
Gnomad4 AMR exome
AF:
0.542
Gnomad4 ASJ exome
AF:
0.477
Gnomad4 EAS exome
AF:
0.582
Gnomad4 SAS exome
AF:
0.487
Gnomad4 FIN exome
AF:
0.477
Gnomad4 NFE exome
AF:
0.434
Gnomad4 OTH exome
AF:
0.451
GnomAD4 genome
AF:
0.437
AC:
66409
AN:
151934
Hom.:
14708
Cov.:
31
AF XY:
0.443
AC XY:
32912
AN XY:
74246
show subpopulations
Gnomad4 AFR
AF:
0.376
Gnomad4 AMR
AF:
0.481
Gnomad4 ASJ
AF:
0.477
Gnomad4 EAS
AF:
0.574
Gnomad4 SAS
AF:
0.501
Gnomad4 FIN
AF:
0.481
Gnomad4 NFE
AF:
0.441
Gnomad4 OTH
AF:
0.427
Alfa
AF:
0.443
Hom.:
19892
Bravo
AF:
0.433
Asia WGS
AF:
0.513
AC:
1779
AN:
3478
EpiCase
AF:
0.453
EpiControl
AF:
0.451

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 06, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 29, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Cobalamin C disease Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 25, 2016Variant summary: The c.321G>A in MMACHC gene is a synonymous change that involves a non-conserved nucleotide. 3/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at an overall frequency of 47%, suggesting it is a common polymorphism. The variant has been reported as Benign by several reputable databases/clinical laboratories. Taken together, this variant has been classified as Benign. -
Disorders of Intracellular Cobalamin Metabolism Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
2.2
DANN
Benign
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2275276; hg19: chr1-45973928; COSMIC: COSV53113363; COSMIC: COSV53113363; API